Nanalysis Scientific Corp
XTSX:NSCI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.335
0.58
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NSCI stock under the Base Case scenario is 0.612 CAD. Compared to the current market price of 0.365 CAD, Nanalysis Scientific Corp is Undervalued by 40%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Nanalysis Scientific Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NSCI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Nanalysis Scientific Corp
Balance Sheet Decomposition
Nanalysis Scientific Corp
Current Assets | 17.7m |
Cash & Short-Term Investments | 1.1m |
Receivables | 9.8m |
Other Current Assets | 6.8m |
Non-Current Assets | 33.7m |
Long-Term Investments | 5.3m |
PP&E | 4.1m |
Intangibles | 21.1m |
Other Non-Current Assets | 3.2m |
Current Liabilities | 12.5m |
Accounts Payable | 6.9m |
Other Current Liabilities | 5.6m |
Non-Current Liabilities | 14.8m |
Long-Term Debt | 13.6m |
Other Non-Current Liabilities | 1.2m |
Earnings Waterfall
Nanalysis Scientific Corp
Revenue
|
39.5m
CAD
|
Cost of Revenue
|
-30.6m
CAD
|
Gross Profit
|
8.9m
CAD
|
Operating Expenses
|
-16.4m
CAD
|
Operating Income
|
-7.5m
CAD
|
Other Expenses
|
-5.4m
CAD
|
Net Income
|
-12.9m
CAD
|
Free Cash Flow Analysis
Nanalysis Scientific Corp
CAD | |
Free Cash Flow | CAD |
In its latest earnings call, Nanalysis Scientific reported a record revenue of $11.5 million for Q2 2024, reflecting a 65% increase from last year. The gross margin on product sales was 50%, aided by manufacturing cost reductions. The company also achieved positive adjusted EBITDA of $414,000, up from a loss of $2.4 million a year prior. Growth in the Benchtop NMR business and improved performance in security services drove this success. Looking ahead, the company expects continued momentum and product innovations as it targets over 25% gross margins in services. Nanalysis aims to maintain strong revenue growth while managing costs effectively.
What is Earnings Call?
NSCI Profitability Score
Profitability Due Diligence
Nanalysis Scientific Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Nanalysis Scientific Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
NSCI Solvency Score
Solvency Due Diligence
Nanalysis Scientific Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Nanalysis Scientific Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSCI Price Targets Summary
Nanalysis Scientific Corp
According to Wall Street analysts, the average 1-year price target for NSCI is 1.224 CAD with a low forecast of 1.212 CAD and a high forecast of 1.26 CAD.
Dividends
Current shareholder yield for NSCI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. The firm operates through three segments: Nanalysis, RS2D and Corporate. Through its European subsidiary RS2D S.A.S. (RS2D), the Company also manufactures and distributes electronic boards and software are used in nuclear magnetic resonance (NMR) and MRI equipment. Its 60 and 100 megahertz (MHz) spectrometers incorporate permanent magnets and require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology. The Company’s product offerings are based upon its magnet technology, as well as its Cam4 technology.
Contact
IPO
Employees
Officers
The intrinsic value of one NSCI stock under the Base Case scenario is 0.612 CAD.
Compared to the current market price of 0.365 CAD, Nanalysis Scientific Corp is Undervalued by 40%.